Professional Experience
Joshua Davis practices complex patent litigation with an emphasis on pharmaceuticals and biotechnology.
While at Yale University, Mr. Davis was part of a group studying ribozymes and the structure of protein/RNA complexes.
Prior to attending law school, Mr. Davis worked at The Scripps Research Institute where he studied the structure and function of multiprotein complexes involved in genetic regulation.
During his time at Emory University, Mr. Davis was Executive Managing Editor of the Emory International Law Review. Mr. Davis also graduated from Emory with a Certificate in Intellectual Property for his work in the area of technology commercialization.
Professional Activities
American Intellectual Property Law Association; New York Intellectual Property Law Association
Additional Publications
Yuichiro Takagi, James Z. Chadick, Joshua A. Davis, and Francisco J. Asturias, "Preponderance of Free Mediator in the Yeast Saccharomyces cerevisiae." 280 J. Biol. Chem. 31200-31207 (2005).
Joshua A. Davis, Yuichiro Takagi, Roger D. Kornberg, and Francisco J. Asturias, "Structure of the Yeast RNA Polymerase II Holoenzyme: Mediator Conformation and Polymerase Interaction." 10(2) Mol. Cell. 409-415 (2002).
Decisions
Representative Cases
AstraZeneca Pharmaceuticals LP et al. v. Anchen Pharmaceuticals Inc. et al.
D.N.J. 2012
Sanofi-Aventis U.S. LLC et al. v. Sun Pharmaceutical Industries Ltd. et al.
D.N.J. 2011
Hoechst GmbH v. Genentech, Inc.
ICC International Court of Arbitration 2011
Sanofi-Aventis U.S. LLC, Sanofi-Aventis, and Debiopharm S.A. v. Sandoz, Inc. et al.
Fed. Cir. 2009
Sanofi-Synthelabo, et al. v. Apotex, Inc.
Fed. Cir. 2008
Sanofi-Synthelabo, et al. v. Apotex Inc.
S.D.N.Y. 2007
Publications/Events
Events
The Use of Reexamination As a Litigation Tactic
AIPLA 2007 Spring Meeting
May 9-11, 2007